Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

The Safety and Effectiveness of Nevirapine Plus Lamivudine Plus Other Anti-HIV Drugs

ClinicalTrials.gov ID: NCT00002368

Public ClinicalTrials.gov record NCT00002368. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 12:11 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An International, Double Blind, Randomized, Phase III Study to Evaluate the Tolerance, Safety, and Effectiveness of Viramune (Nevirapine) in Preventing Clinical AIDS Progression Events or Death When Used in Combination With Lamivudine (3TC) and Stable (>= 4 Weeks) Background Nucleoside Therapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To evaluate the tolerance, safety, and effectiveness of Viramune in preventing clinical AIDS progression events or death when used in combination with Lamivudine and background nucleoside therapy.

Study identification

NCT ID
NCT00002368
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Boehringer Ingelheim
Industry
Enrollment
2,000 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
13 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Not listed
Last update posted
Jun 24, 2005

United States locations

U.S. sites
53
U.S. states
25
U.S. cities
44
Facility City State ZIP Site status
Drug Research and Analysis Corp Montgomery Alabama 36104 —
Dr G Michael Wool Los Angeles California 90067 —
UCLA School of Medicine / Ctr for Research and Education Los Angeles California 900951793 —
AIDS Research Ctr / Palo Alto VA Health Care System Palo Alto California 94304 —
AIDS Community Research Consortium Redwood City California 94063 —
ViRx Inc San Francisco California 94109 —
San Francisco Gen Hosp / UCSF AIDS Program San Francisco California 94110 —
Harbor - UCLA Med Ctr Torrance California 90502 —
Infectious Disease Specialists Colorado Springs Colorado 80903 —
Denver Public Health Denver Colorado 80204 —
Dr Miguel Mogyoros / Clinical Research Dept Denver Colorado 80205 —
Wilmington Hosp Wilmington Delaware 19801 —
Novum Inc Washington D.C. District of Columbia 20037 —
Anthony LaMarca Fort Lauderdale Florida 33308 —
North Broward Hosp District Fort Lauderdale Florida 33316 —
Dr Robert Schwartz Fort Myers Florida 33901 —
McGregor Clinic / Lee County Public Health Unit Fort Myers Florida 33901 —
P Andrew Coley Jacksonville Florida 32216 —
Goodgame Med Group Maitland Florida 32751 —
Infectious Disease Research Institute Inc Tampa Florida 33614 —
Palm Beach Research Ctr West Palm Beach Florida 33409 —
Dr John Pottage Chicago Illinois 60610 —
Northwestern Univ / Division of Infectious Diseases Chicago Illinois 60611 —
Rush Presbyterian / Saint Luke's Med Ctr / Infect Dis Chicago Illinois 60612 —
Indiana Univ Med School Indianapolis Indiana 46202 —
Dr Daniel H Gervich Des Moines Iowa 50325 —
Univ of Iowa Iowa City Iowa 52242 —
Univ of Kentucky Med Cntr / Dept of Med / Div of ID Lexington Kentucky 40563 —
Med Research Ctr New Orleans Louisiana 70112 —
New England Med Ctr Boston Massachusetts 02111 —
Beth Israel Hosp / Virology Research Clinic Boston Massachusetts 02215 —
New England Deaconess Hosp Boston Massachusetts 02215 —
International Medicine and Infectious Disease Minneapolis Minnesota 55407 —
Trinity Lutheran Hosp / HIV Program Kansas City Missouri 64108 —
Infectious Disease Associates of Central New Jersey Somerville New Jersey 08876 —
SUNY / Erie County Med Ctr at Buffalo Buffalo New York 14215 —
Dr David Kaufman New York New York 10014 —
Saint Vincent Med Ctr Staten Island New York 10310 —
Associates in Med and Mental Health Tulsa Oklahoma 74114 —
The Research and Education Group Portland Oregon 97210 —
Hershey Med Ctr / Dept of Med / Div of Hematology Hershey Pennsylvania 17033 —
Univ of Pennsylvania / Division of Infectious Diseases Philadelphia Pennsylvania 19104 —
Novum Inc Pittsburgh Pennsylvania 152063817 —
Omega Med Research Providence Rhode Island 02907 —
Med Univ of South Carolina / Div of Infect Dis Charleston South Carolina 29425 —
Dr Alfred Burnside Columbia South Carolina 29206 —
Dr Susie Sargent Memphis Tennessee 38163 —
Nelson Tebedo Health Resource Ctr Dallas Texas 75219 —
Univ of Texas Med Branch / Div of Infectious Dis Galveston Texas 775550835 —
Houston Clinical Research Network / Div of Montrose Clinic Houston Texas 77006 —
Walter Gaman Irving Texas 75038 —
Hampton Roads Med Specialists Hampton Virginia 23666 —
Advanced Research Management Seattle Washington 981225314 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00002368, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 24, 2005 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00002368 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →